Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Contributions of Pain Interference and Affect to Patient-Reported Opioid Benefit in Chronic Pain Management

View ORCID ProfileAnne K. Baker, View ORCID ProfileSu Hyoun Park, Morgan A. Rosser, Meghna Nanda, View ORCID ProfileKatherine T. Martucci
doi: https://doi.org/10.1101/2022.12.28.22284000
Anne K. Baker
1Human Affect and Pain Neuroscience Laboratory, Department of Anesthesiology, Duke University School of Medicine, Durham NC 27710
2Center for Translational Pain Medicine, Duke University Medical Center, Durham NC 27710
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anne K. Baker
Su Hyoun Park
1Human Affect and Pain Neuroscience Laboratory, Department of Anesthesiology, Duke University School of Medicine, Durham NC 27710
2Center for Translational Pain Medicine, Duke University Medical Center, Durham NC 27710
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Su Hyoun Park
Morgan A. Rosser
3Department of Anesthesiology, Biostatistics Group, Duke University School of Medicine, Durham NC 27710
M.S.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meghna Nanda
1Human Affect and Pain Neuroscience Laboratory, Department of Anesthesiology, Duke University School of Medicine, Durham NC 27710
2Center for Translational Pain Medicine, Duke University Medical Center, Durham NC 27710
B.S.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katherine T. Martucci
1Human Affect and Pain Neuroscience Laboratory, Department of Anesthesiology, Duke University School of Medicine, Durham NC 27710
2Center for Translational Pain Medicine, Duke University Medical Center, Durham NC 27710
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Katherine T. Martucci
  • For correspondence: katherine.martucci{at}duke.edu anne.baker{at}duke.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Despite known deleterious consequences associated with long-term opioid use, many individuals with chronic pain assert opioid benefits and advocate for continued opioid use. However, relative to non-opioid using chronic pain patients, opioid-using patients typically report greater pain severity and depression. Moreover, there appears to be no significant association between pain severity or interference and perceived opioid benefit among chronic pain patients. Thus, pain reduction itself might not directly relate to patients’ perceptions of opioid benefit. Given extensive prior research revealing significant overlaps between pain and affect, it is prudent to examine contributions of affective disturbances—alongside pain-related factors—to perceived opioid benefits. In the present study, we examined the hierarchical contributions of pain interference and positive affect in predicting self-reported opioid benefit. We hypothesized that positive affect combined with pain interference would best predict opioid benefit.

Methods We examined multisite, cross-sectional data collected from females with fibromyalgia who were using opioids long-term (n = 40) and who were not regularly using opioids but had used them acutely (< 30 days) at least once previously (n = 25). Patients completed a set of questionnaires, including the Positive and Negative Affect Schedule, the Brief Pain Inventory, and a novel measure querying perceived opioid benefit on a 0-10 Likert scale (0 = not at all, 10 = completely). We examined relationships between pain interference, positive affect, and patient-reported opioid benefit using logistic regression.

Results Among opioid-using patients, pain interference combined with positive affect was a better model for opioid benefit (AIC = 52.15) compared to pain interference alone (AIC = 57.80). However, among non-opioid using patients, pain interference alone was a better model for opioid benefit (AIC = 28.00) than pain interference combined with positive affect (AIC = 28.12).

Conclusions Among patients using opioids long-term, affective factors may be primary drivers of perceived opioid benefit. Positive affect combined with pain interference modeled opioid benefit better than pain interference alone among opioid-using chronic pain patients, but not among non-opioid-using chronic pain patients. Importantly, post-hoc analyses examining the contributions of negative affect further validated the main findings; positive affect out-performed negative affect in all models. Thus, perceived opioid benefit may be a function of cumulative opioid-induced enhancements in positive affect. Based on these results, examination of factors besides pain reduction may be critical to understanding perceived opioid benefit among chronic pain patients; this understanding is essential for development of effective, opioid-sparing treatments.

Question Does the combination of pain and affect predict patient-reported (i.e., perceived) opioid benefit better than pain alone, and do these relationships differ between groups of opioid-using and non-opioid using individuals with chronic pain?

Findings Compared to pain interference alone, pain interference combined with positive affect was a better model of perceived opioid benefit among opioid-using chronic pain patients, but not among non-opioid using chronic pain patients, who had used opioids acutely at least once previously.

Meaning Among patients with chronic pain using opioid medications long-term, perceived opioid benefit appears to be a consequence of opioid-related enhancements in positive affect rather than pain reduction per se.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This project was funded by the National Institutes of Health, National Institute of Drug Abuse (NIDA), K99/R00 DA040154 and R01 DA055850 (awarded to K.T.M.).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All participants completed written informed consent prior to data collection and all study procedures were approved by the Stanford University and Duke University Institutional Review Boards. An IRB-approved Data Use Agreement was created to allow for the data collected at Stanford University to be analyzed by the research team at Duke University.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Financial Disclosures: This project was funded by the National Institutes of Health, National Institute of Drug Abuse (NIDA), K99/R00 DA040154 and R01 DA055850 (awarded to K.T.M.).

  • Conflicts of Interest: None

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 30, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Contributions of Pain Interference and Affect to Patient-Reported Opioid Benefit in Chronic Pain Management
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Contributions of Pain Interference and Affect to Patient-Reported Opioid Benefit in Chronic Pain Management
Anne K. Baker, Su Hyoun Park, Morgan A. Rosser, Meghna Nanda, Katherine T. Martucci
medRxiv 2022.12.28.22284000; doi: https://doi.org/10.1101/2022.12.28.22284000
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Contributions of Pain Interference and Affect to Patient-Reported Opioid Benefit in Chronic Pain Management
Anne K. Baker, Su Hyoun Park, Morgan A. Rosser, Meghna Nanda, Katherine T. Martucci
medRxiv 2022.12.28.22284000; doi: https://doi.org/10.1101/2022.12.28.22284000

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pain Medicine
Subject Areas
All Articles
  • Addiction Medicine (427)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3284)
  • Dentistry and Oral Medicine (362)
  • Dermatology (275)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1166)
  • Epidemiology (13346)
  • Forensic Medicine (19)
  • Gastroenterology (898)
  • Genetic and Genomic Medicine (5137)
  • Geriatric Medicine (480)
  • Health Economics (781)
  • Health Informatics (3260)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1189)
  • Hematology (428)
  • HIV/AIDS (1015)
  • Infectious Diseases (except HIV/AIDS) (14615)
  • Intensive Care and Critical Care Medicine (910)
  • Medical Education (476)
  • Medical Ethics (126)
  • Nephrology (522)
  • Neurology (4907)
  • Nursing (262)
  • Nutrition (725)
  • Obstetrics and Gynecology (880)
  • Occupational and Environmental Health (795)
  • Oncology (2517)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (540)
  • Pediatrics (1299)
  • Pharmacology and Therapeutics (548)
  • Primary Care Research (554)
  • Psychiatry and Clinical Psychology (4196)
  • Public and Global Health (7488)
  • Radiology and Imaging (1703)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (479)
  • Sexual and Reproductive Health (495)
  • Sports Medicine (424)
  • Surgery (547)
  • Toxicology (72)
  • Transplantation (235)
  • Urology (203)